Treatment with P-chloroamphetamine enhances the development of neuroleptic-induced orofacial dyskinesias in the rat.
Sandyk
R
R
Tokyo Metropolitan Institute for Neurosciences, Japan.
Fisher
H
H
D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D004409:Dyskinesia, Drug-Induced / Q000378:metabolism* / Q000503:physiopathology; D005152:Facial Muscles / Q000503:physiopathology*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*; D010133:p-Chloroamphetamine / Q000494:pharmacology*
D000662:Amphetamines; D014150:Antipsychotic Agents; D012701:Serotonin; D010133:p-Chloroamphetamine; D006220:Haloperidol